Average Co-Inventor Count = 4.28
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astrazeneca Ab (6 from 1,500 patents)
2. Integrative Research Laboratories Sweden Ab (2 from 9 patents)
3. Nsab, Filial Af Neurosearch Sweden Ab, Sverige (1 from 7 patents)
4. Integrated Research Laboratories Sweden Ab (1 from 1 patent)
10 patents:
1. 9120728 - Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
2. 9006227 - Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
3. 8524766 - Modulators of dopamine neurotransmission
4. 8492372 - Modulators of dopamine neurotransmission
5. 7772229 - Oxabispidine compounds useful in the treatment of cardiac arrhythmias
6. 7351821 - Oxabispidine compounds useful in the treatment of cardiac arrhythmias
7. 7144914 - 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
8. 7012074 - 3,8-Diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias
9. 6559162 - Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
10. 6559143 - Oxabispidine compounds useful in the treatment of cardiac arrhyythmias